My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Ann Clin Microbiol Antimicrob. 2009 Apr 15;8:12.

    Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.

    Soylu A, Ince AT, Polat H, Yasar N, Ciltas A, Ozkara S, Tasci AI.

    Department of Gastroenterology, Bakirkoy Training and Research Hospital, Istanbul, Turkey. aliyesoylu@superonline.com

    Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is generally well tolerated, serious side effects may develop. Granulomatous hepatitis cases have been previously reported; however, only one case with tuberculous peritonitis exists in the current literature. We hereby present two cases, one of which is the second tubercular peritonitis case following Bacillus Calmette-Guérin treatment to be reported, and the other a case with granulomatous hepatitis. Complete cure was achieved in both cases with specific therapy. In the patient who developed peritonitis, intravesical Bacillus Calmette-Guérin therapy was recommenced after antituberculosis treatment, and completed without further complications.

    PMID: 19368735 [PubMed - indexed for MEDLINE]

    PMCID: PMC2672069

    Supplemental Content

    Click here to read Click here to read
    Write to the Help Desk